Blood Investigation for SLE
Begin with ANA testing as the mandatory entry criterion—a positive ANA (≥1:80) is required before proceeding with further SLE-specific testing, as 99% of SLE patients are ANA-positive. 1
Initial Screening
- ANA (Antinuclear Antibody): This is your first-line screening test with 98% sensitivity for SLE 1
- Use indirect immunofluorescence on HEp-2 cells as the method of choice 2
- A titer of ≥1:80 is considered positive
- Critical caveat: While highly sensitive, ANA has low specificity—it can be positive in other conditions and even healthy individuals 2
- If ANA is persistently negative, the 2019 EULAR/ACR criteria cannot classify the patient as SLE, though a small subset of ANA-negative SLE exists 1
Confirmatory and Specific Antibody Testing
Once ANA is positive, proceed with:
SLE-Specific Antibodies (Highest Priority)
Anti-dsDNA antibodies: Highly specific for SLE (40-80% of patients) 2
Anti-Smith (Anti-Sm) antibodies: Highly specific for SLE
- Carries 6 points in the classification criteria 1
Anti-ENA (Extractable Nuclear Antigen) Panel
When ANA is positive, confirmatory anti-ENA testing is recommended 3. Test for:
- Anti-Ro (SSA)
- Anti-La (SSB)
- Anti-RNP
- Anti-Sm
- Ribosomal P protein
- Chromatin antibodies 3
Additional Antibodies for Specific Clinical Contexts
Anti-nucleosome antibodies: 83% sensitivity and 97% specificity for SLE 3
- Particularly useful when clinical suspicion is high but anti-dsDNA is negative
- Can precede ANA positivity in SLE pathogenesis 3
Antiphospholipid antibodies (when clinical features suggest antiphospholipid syndrome):
- Anticardiolipin antibodies
- Anti-β2-glycoprotein I
- Lupus anticoagulant
- Present in 30-40% of SLE patients 3
Complement and Hematological Testing
Complement Levels
C3 and C4: Essential for both diagnosis and monitoring
CH50: Useful in renal involvement monitoring 4
Complete Blood Count with Differential
The following hematological abnormalities carry diagnostic weight:
Renal Function Tests
- Proteinuria: 4 points if present 1
- Serum creatinine and urinalysis
Specialized Testing for Lupus Nephritis
When renal involvement is suspected or confirmed:
Anti-C1q antibodies: The best marker for lupus nephritis activity 4
sC5b-9 (soluble terminal complement complex): Elevated in active lupus nephritis 4
Monitoring vs. Diagnosis: Key Distinctions
Do NOT repeat ANA testing for monitoring—it is not cost-effective and not recommended once initially positive 3. For established SLE:
Use for Monitoring:
- Anti-dsDNA (quantitative method, same laboratory) 3
- Complement levels (C3, C4, CH50) even if previously normal 3
- Anti-C1q for lupus nephritis activity 3
- Anti-nucleosome for dsDNA-negative lupus nephritis patients 3
Do NOT Use for Monitoring:
- ANA testing 3
Important Clinical Pitfalls
Serologically active but clinically quiescent disease: Some patients maintain positive serology without clinical activity 3
dsDNA-negative lupus nephritis: Membranous lupus nephritis can occur with negative anti-dsDNA—use anti-nucleosome or anti-C1q instead 3
Anti-histone antibodies: More prevalent in drug-induced lupus, so use cautiously and only when drug-induced SLE is excluded 3
ELISA for anti-dsDNA: Avoid for initial diagnosis due to low specificity; reserve for quantitative monitoring if initially diagnosed with this method 2